FULC
Price
$4.36
Change
+$0.33 (+8.19%)
Updated
Dec 20, 04:59 PM (EDT)
68 days until earnings call
TSHA
Price
$1.85
Change
+$0.01 (+0.54%)
Updated
Dec 20, 04:59 PM (EDT)
95 days until earnings call
Ad is loading...

FULC vs TSHA

Header iconFULC vs TSHA Comparison
Open Charts FULC vs TSHABanner chart's image
Fulcrum Therapeutics
Price$4.36
Change+$0.33 (+8.19%)
Volume$13.22K
CapitalizationN/A
Taysha Gene Therapies
Price$1.85
Change+$0.01 (+0.54%)
Volume$12.86K
CapitalizationN/A
FULC vs TSHA Comparison Chart
Loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FULC vs. TSHA commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and TSHA is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (FULC: $4.36 vs. TSHA: $1.85)
Brand notoriety: FULC and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 315% vs. TSHA: 117%
Market capitalization -- FULC: $235.44M vs. TSHA: $379.15M
FULC [@Biotechnology] is valued at $235.44M. TSHA’s [@Biotechnology] market capitalization is $379.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than TSHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 4 bullish TA indicator(s).

  • FULC’s TA Score: 6 bullish, 4 bearish.
  • TSHA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, FULC is a better buy in the short-term than TSHA.

Price Growth

FULC (@Biotechnology) experienced а +10.23% price change this week, while TSHA (@Biotechnology) price change was -10.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

FULC is expected to report earnings on Feb 27, 2025.

TSHA is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($379M) has a higher market cap than FULC($235M). TSHA YTD gains are higher at: 4.520 vs. FULC (-35.333). TSHA has higher annual earnings (EBITDA): -20.67M vs. FULC (-26.67M). FULC has more cash in the bank: 257M vs. TSHA (158M). FULC has less debt than TSHA: FULC (9.15M) vs TSHA (62.5M). FULC has higher revenues than TSHA: FULC (80.9M) vs TSHA (9.92M).
FULCTSHAFULC / TSHA
Capitalization235M379M62%
EBITDA-26.67M-20.67M129%
Gain YTD-35.3334.520-782%
P/E RatioN/A2.94-
Revenue80.9M9.92M816%
Total Cash257M158M163%
Total Debt9.15M62.5M15%
TECHNICAL ANALYSIS
Technical Analysis
FULCTSHA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
View a ticker or compare two or three
Ad is loading...
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TSHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VALIX12.850.16
+1.26%
Value Line Capital Appreciation Investor
MACCX16.070.17
+1.07%
MoA Catholic Values Index Fund Class
TRZKX63.140.44
+0.70%
T. Rowe Price International Discovery Z
JACFX18.65N/A
N/A
JHancock Mid Cap Growth NAV
GIRVX6.72-0.01
-0.15%
Goldman Sachs Intl Eq Div & Prem Inv

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+8.31%
ONCT - FULC
55%
Loosely correlated
N/A
SLS - FULC
48%
Loosely correlated
+0.29%
ANNX - FULC
40%
Loosely correlated
+0.77%
VRDN - FULC
39%
Loosely correlated
+1.66%
MLTX - FULC
34%
Loosely correlated
+0.56%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with LOGC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then LOGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
N/A
LOGC - TSHA
45%
Loosely correlated
+1.51%
AURA - TSHA
35%
Loosely correlated
+1.23%
ORMP - TSHA
35%
Loosely correlated
-4.42%
ARWR - TSHA
35%
Loosely correlated
-0.18%
PRME - TSHA
34%
Loosely correlated
+4.66%
More